Skip to content

Phase 3b Pilot study evaluating the Acceptability and Adherence of Multiple Micronutrient Supplementation (MMS) Compared with Iron-Folic Acid (IFA) within Antenatal Care in Johannesburg, South Africa

Phase 3b Pilot study evaluating the Acceptability and Adherence of Multiple Micronutrient Supplementation (MMS) Compared with Iron-Folic Acid (IFA) within Antenatal Care in Johannesburg, South Africa

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
PACTR
Registry ID
PACTR202605556476837
Enrollment
795
Registered
2026-05-29
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine Pregnancy and Childbirth

Interventions

Sponsors

WHC WITS HEALTH CONSORTIUM PTY LTD
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: • Healthy pregnant women aged = 18 and =45 years of age, including pregnant women living with HIV (PWLHIV). • PWLHIV will be eligible irrespective of disease control, treatment regimen or treatment duration. • Pregnant women = 14 and = 32 weeks gestational age (GA) to allow for a reasonable period of follow-up and birth outcome collection, as determined by study GA definition. • Attending ANC at any of the participating Region F primary health care facilities. • Fluent in the population widely-spoken local language in which the interview can be conducted (English, IsiZulu, SeSotho). • Ability to read write and understand study document language (as above). Illiterate women will not be excluded, family member/friend can be enlisted to assist with study document completion. • Willing and able to provide written informed consent as well as understand ICFs

Exclusion criteria

Exclusion criteria: • History of adverse reaction to any of the study product ingredients. • Presence of pregnancy-related complications or abnormalities at the time of consent that, in the opinion of the study nurse/investigator, may increase the risk associated with study participation or completion, including but not limited to uncontrolled comorbidities as per participant report and maternal case report review. • Currently diagnosed with any micronutrient deficiency, requiring further participant-based management. • Taking any of the prohibited medication listed in Section 10.1.

Design outcomes

Primary

MeasureTime frame
Acceptability;Adherence

Secondary

MeasureTime frame
Qualitative Insights;Birth outcomes - Descriptive data on birth outcomes, and maternal wellbeing, consistent with international MMS studies.

Countries

South Africa

Contacts

Public ContactLisa;Elizea Mills;Horne

Project Manager;Principal Investigator

lmills@wrhi.ac.za;ehorne@wrhi.ac.za0113585300;+27113585300

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026